Audited Results of Jubilant Pharmova Ltd. Company

(Rs in Cr.) Mar 31, 2026 Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Operating Income 263.50 745.70 784.70 810.12 87.75
Manufacturing Expenses 0 78 68.40 75.37 9.27
Personnel Expenses 103.80 203 190 167.27 49.21
Selling Expenses 0 3.80 3 1.43 0.33
Administrative Expenses 110.90 133.70 128.50 148.26 35.72
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 214.70 713.60 768.20 806.89 94.53
Operating Profit 48.80 32.10 16.50 3.23 -6.79
Other Recurring Income 2.40 99.60 103.40 137.89 125.87
Adjusted PBDIT 51.20 131.70 119.90 141.12 119.08
Financial Expenses 7.30 29.80 29.90 18.52 30.59
Depreciation 6 53.10 48.30 43.25 6.25
Other Write offs 0 0 0 0 0
Adjusted PBT 37.90 48.80 41.70 79.34 82.25
Tax Charges 9.30 18.40 10.10 29.46 3.75
Adjusted PAT 28.60 30.40 31.60 49.88 78.50
Non Recurring Items 34.60 -11.50 -0.20 -0.77 0.25
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 63.20 19.20 31.60 49.88 78.50
Equity Dividend 0 79.60 79.60 79.64 79.64
Preference Dividend 0 0 0 0 0
Retained Earnings 63.20 1,014.90 1,075.40 1,123.50 1,154.03

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+